Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of bromodomain and extra-terminal (BET) proteins with JQ1 exacerbates acetaminophen-induced hepatotoxicity by altering detoxification pathways and oxidative stress responses. | Chem Biol Interact | 2025 | 40157625 | PubTator, text mining | PubMed |
| Micheliolide Alleviates Hepatic Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via the TrxR1/2-Mediated ROS/MEK/ERK Pathway. | Pharmaceuticals (Basel) | 2025 | 40143066 | PubTator, text mining | PubMed |
| Copper Hexacyanoferrates Obtained via Flavocytochrome b2 Assistance: Characterization and Application. | Biosensors (Basel) | 2025 | 40136954 | PubTator, text mining | PubMed |
| A general approach for activity-based protein profiling of oxidoreductases with redox-differentiated diarylhalonium warheads. | Chem Sci | 2025 | 40103729 | PubTator, text mining | PubMed |
| Environmentally relevant concentrations of antimony pose potential risks to human health: An evaluation on human umbilical vein endothelial cells. | Toxicol In Vitro | 2025 | 40086647 | PubTator, text mining | PubMed |
| Unraveling the multifaceted roles of peroxiredoxins in sickle cell anemia: implications in redox and inflammation adaptations. | Ann Hematol | 2025 | 40085210 | PubTator, text mining | PubMed |
| Insights into the cellular function and mechanism of action of quinone reductase 2 (NQO2). | Biochem J | 2025 | 40071447 | PubTator, text mining | PubMed |
| Protein disulfide isomerase is essential for osteoblast differentiation in mice. | Commun Biol | 2025 | 40065084 | PubTator, text mining | PubMed |
| Nucleoredoxin regulates WNT signaling during pituitary stem cell differentiation. | Hum Mol Genet | 2025 | 40044116 | PubTator, text mining | PubMed |
| Role of protein disulfide isomerase in mediating sulfasalazine-induced ferroptosis in HT22 cells: The PDI-NOS-NO-ROS/lipid-ROS cascade. | Arch Biochem Biophys | 2025 | 40023379 | PubTator, text mining | PubMed |
| Cellular activity of the cytosolic selenoprotein thioredoxin reductase 1 (TXNRD1) is modulated by copper and zinc levels in the cell culture medium. | J Trace Elem Med Biol | 2025 | 39983285 | PubTator, text mining | PubMed |
| Insights on the crosstalk among different cell death mechanisms. | Cell Death Discov | 2025 | 39929794 | PubTator, text mining | PubMed |
| Re-Sensitization of Resistant Ovarian Cancer SKOV3/CDDP Cells to Cisplatin by Curcumin Pre-Treatment. | Int J Mol Sci | 2025 | 39859517 | PubTator, text mining | PubMed |
| Correlation between selenium levels and selenoproteins expression in idiopathic generalized epilepsy: a study from Karachi. | BMC Neurol | 2025 | 39849427 | PubTator, text mining | PubMed |
| Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach. | Sci Rep | 2025 | 39848951 | PubTator, text mining | PubMed |
| A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome. | Cancer Chemother Pharmacol | 2025 | 39821392 | PubTator, text mining | PubMed |
| Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma. | Biol Direct | 2025 | 39815362 | PubTator, text mining | PubMed |
| Sulforaphane potentiates the efficacy of chemoradiotherapy in glioblastoma by selectively targeting thioredoxin reductase 1. | Cancer Lett | 2025 | 39725145 | PubTator, text mining | PubMed |
| Essential role of sulfide oxidation in brain health and neurological disorders. | Pharmacol Ther | 2025 | 39719173 | PubTator, text mining | PubMed |
| Synthesis of Thiazolidinedione- and Triazole-Linked Organoselenocyanates and Evaluation of Anticancer Activities Against Breast Cancer with Mechanistic Investigations. | Chemistry | 2025 | 39630055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=15